Preclinical data suggests that anti-PD-1 therapy and radiotherapy are best given concurrently, as there may be significant synergy between these two therapies [ 50 , 51 ].
← all excerpts
A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of Immunotherapy.
1
—
—